Literature DB >> 8467289

Treatment of experimental allergic encephalomyelitis in rats with total body irradiation and syngeneic BMT.

M van Gelder1, E P Kinwel-Bohré, D W van Bekkum.   

Abstract

Experimental allergic encephalomyelitis (EAE) was induced in Buffalo rats by immunization with syngeneic spinal cord homogenate in complete adjuvant. EAE, an autoimmune disease of the central nervous system (CNS), is regarded as a model for multiple sclerosis. When severe paresis had developed, rats were treated with high-dose total body irradiation (TBI) and transplanted with syngeneic BM from healthy donors. Nine Gy TBI followed by syngeneic BMT greatly accelerated recovery of paresis compared with untreated controls. In 6-33% of the treated animals a relapse of EAE was observed shortly after treatment. Reimmunization 20 days after treatment, resulted in a relapse in 12-44% of the rats. Employing the maximally tolerated dose of TBI (10 Gy) did not significantly alter the incidence of spontaneous or induced relapses. Furthermore, it was shown that irradiation of the CNS only was not sufficient for the induction of complete regression of paresis. The origin of the cells responsible for these relapses is discussed, as is the importance of reimmunization in evaluating the effect of treatment of experimental autoimmune disease.

Entities:  

Mesh:

Year:  1993        PMID: 8467289

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  21 in total

Review 1.  Prospects of stem cell transplantation in autoimmune diseases.

Authors:  R A Nash
Journal:  J Clin Immunol       Date:  2000-01       Impact factor: 8.317

Review 2.  Immune ablation and stem-cell therapy in autoimmune disease. Experimental basis for autologous stem-cell transplantation.

Authors:  D W Bekkum
Journal:  Arthritis Res       Date:  2000-06-02

Review 3.  Adult stem cell therapy for autoimmune disease.

Authors:  Eun Wha Choi
Journal:  Int J Stem Cells       Date:  2009-05       Impact factor: 2.500

4.  Intense T cell depletion followed by autologous bone marrow transplantation for severe multiple sclerosis.

Authors:  J P A Samijn; P A W te Boekhorst; T Mondria; P A van Doorn; H Z Flach; F G A van der Meché; J Cornelissen; W C Hop; B Löwenberg; R Q Hintzen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-01       Impact factor: 10.154

Review 5.  Optimisation of cyclophosphamide therapy in systemic vasculitis.

Authors:  R Richmond; T W McMillan; R A Luqmani
Journal:  Clin Pharmacokinet       Date:  1998-01       Impact factor: 6.447

6.  Haemopoietic stem and progenitor cells in the treatment of severe autoimmune diseases.

Authors:  A Tyndall; A Gratwohl
Journal:  Ann Rheum Dis       Date:  1996-03       Impact factor: 19.103

7.  Purified hematopoietic stem cell transplantation: the next generation of blood and immune replacement.

Authors:  Agnieszka Czechowicz; Irving L Weissman
Journal:  Hematol Oncol Clin North Am       Date:  2011-02       Impact factor: 3.722

Review 8.  Stem cell transplantation in experimental models of autoimmune disease.

Authors:  D W van Bekkum
Journal:  J Clin Immunol       Date:  2000-01       Impact factor: 8.317

9.  Immunomodulation of autoimmunity in MRL/lpr mice with syngeneic bone marrow transplantation (SBMT).

Authors:  D M Karussis; U Vourka-Karussis; D Lehmann; O Abramsky; A Ben-Nun; S Slavin
Journal:  Clin Exp Immunol       Date:  1995-04       Impact factor: 4.330

10.  High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis.

Authors:  Richard A Nash; James D Bowen; Peter A McSweeney; Steven Z Pavletic; Kenneth R Maravilla; Man-soo Park; Jan Storek; Keith M Sullivan; Jinan Al-Omaishi; John R Corboy; John DiPersio; George E Georges; Theodore A Gooley; Leona A Holmberg; C Fred LeMaistre; Kate Ryan; Harry Openshaw; Julie Sunderhaus; Rainer Storb; Joseph Zunt; George H Kraft
Journal:  Blood       Date:  2003-05-22       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.